Hybrid AF™ Therapy with the EPi-Sense System is the first & ONLY FDA-approved device for minimally invasive ablation therapy to treat LSPAF—the most prevalent and undertreated Afib patient population. Discover the EPi-Sense ST™ device: <a href="https://t.co/zOeFodmoXQ" target="_blank">https://t.co/zOeFodmoXQ</a>
<a href="https://twitter.com/hashtag/Afib?src=hashtag_click" target="_blank">#Afib</a>
